World's Best Scientists 2026 revealed!
Sylvie van der Werf

Sylvie van der Werf

D-Index & Metrics

Immunology

D-Index
74
Citations
28182
World Ranking
2029
National Ranking
76

Overview

Sylvie van der Werf is affiliated with Université Paris Cité in France and focuses their research primarily within the field of Medicine, with an emphasis on Infectious Diseases. Their body of work also spans subfields such as Molecular Biology, Epidemiology, Modeling and Simulation, and Immunology.

The main topics covered by van der Werf include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 detection and testing
  • COVID-19 epidemiological studies
  • Respiratory viral infections research
  • Influenza Virus Research Studies
  • Animal Virus Infections Studies

Van der Werf has published extensively in notable venues, with a particular concentration of work appearing in:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Eurosurveillance
  • SSRN Electronic Journal
  • Nature Communications
  • Viruses

Key recent publications include:

  • "Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies", 2021, Nature Medicine
  • "First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020", 2020, Eurosurveillance
  • "Syncytia formation by SARS-CoV-2-infected cells", 2020, The EMBO Journal
  • "Bat coronaviruses related to SARS-CoV-2 and infectious for human cells", 2022, Nature
  • "Syncytia formation by SARS-CoV-2-infected cells", 2021, The EMBO Journal

Frequent coauthors who have collaborated with van der Werf include:

  • Vincent Enouf
  • Sylvie Behillil
  • Flora Donati
  • Caroline Demeret
  • Bruno Lina

Best Publications

  • Identification of a novel coronavirus in patients with severe acute respiratory syndrome.

    Christian Drosten;Stephan Günther;Wolfgang Preiser;Sylvie van der Werf

  • Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome

    Thijs Kuiken;Ron A.M. Fouchier;Martin Schutten;Guus F. Rimmelzwaan

  • Primary structure, gene organization and polypeptide expression of poliovirus RNA

    Naomi Kitamura;Bert L. Semler;Paul G. Rothberg;Glenn R. Larsen

  • Bat coronaviruses related to SARS-CoV-2 and infectious for human cells

    Unknown

  • Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.

    Delphine Planas;Delphine Planas;Timothée Bruel;Timothée Bruel;Ludivine Grzelak;Florence Guivel-Benhassine;Florence Guivel-Benhassine

  • First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020

    Gianfranco Spiteri;James Fielding;Michaela Diercke;Christine Campese

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission

    Benoit Guery;Julien Poissy;Loubna El Mansouf;Caroline Séjourné

  • Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

    Adam Meijer;Angie Lackenby;Olav Hungnes;Bruno Lina

  • Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility

    Simon Cauchemez;Christophe Fraser;Maria D Van Kerkhove;Christl A Donnelly

  • Evolution of H5N1 avian influenza viruses in Asia

    Jean Thierry Aubin;Saliha Azebi;Amanda Balish;Jill Banks

  • Syncytia formation by SARS-CoV-2-infected cells.

    Julian Buchrieser;Julian Buchrieser;Jérémy Dufloo;Jérémy Dufloo;Jérémy Dufloo;Mathieu Hubert;Mathieu Hubert;Blandine Monel;Blandine Monel

  • Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.

    Pauline Maisonnasse;Jérémie Guedj;Vanessa Contreras;Sylvie Behillil;Sylvie Behillil

  • Residue 627 of PB2 Is a Determinant of Cold Sensitivity in RNA Replication of Avian Influenza Viruses

    Pascale Massin;Sylvie van der Werf;Nadia Naffakh

  • Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E.

    Béatrice Nal;Cheman Chan;Francois Kien;Lewis Siu

  • Monitoring approaches for health-care workers during the COVID-19 pandemic.

    Julia A Bielicki;Julia A Bielicki;Xavier Duval;Xavier Duval;Nina Gobat;Herman Goossens

  • Host restriction of avian influenza viruses at the level of the ribonucleoproteins.

    Nadia Naffakh;Andru Tomoiu;Marie-Anne Rameix-Welti;Sylvie van der Werf

  • A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials.

    Thierry Boge;Michel Rémigy;Sarah Vaudaine;Jérôme Tanguy

  • SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse.

    Frank Konings;Mark D Perkins;Jens H Kuhn;Mark J Pallen

  • Host-range determinants on the PB2 protein of influenza A viruses control the interaction between the viral polymerase and nucleoprotein in human cells.

    Karine Labadie;Emmanuel Dos Santos Afonso;Marie-Anne Rameix-Welti;Sylvie van der Werf

  • A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.

    Ludivine Grzelak;Ludivine Grzelak;Sarah Temmam;Cyril Planchais;Caroline Demeret

Frequent Co-Authors

Vincent Enouf
Vincent Enouf Institut Pasteur
Marc Girard
Marc Girard Institut Pasteur
Bruno Lina
Bruno Lina Claude Bernard University Lyon 1
Jean-Claude Manuguerra
Jean-Claude Manuguerra Institut Pasteur
Yves Jacob
Yves Jacob Institut Pasteur
Marc Eloit
Marc Eloit Institut Pasteur
Marco Vignuzzi
Marco Vignuzzi Institut Pasteur
Olivier Schwartz
Olivier Schwartz Université Paris Cité
Pierre Charneau
Pierre Charneau Institut Pasteur
Frédéric Thomas
Frédéric Thomas University of Montpellier

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related nursing degrees can offer valuable clinical skills and career versatility. Programs like easy nurse practitioner programs to get into provide accessible pathways for advancing healthcare expertise without compromising educational quality.

Specializing further, students might explore mental health-focused options such as the best online psychiatric mental health nurse practitioner programs. These programs emphasize clinical placements, blending theory with hands-on experience vital for patient care in psychiatric and immunological contexts.

Budget-conscious learners can also find the cheapest pmhnp programs online that maintain strong reputations and accreditation. Affordability in education ensures more individuals can enter health professions, ultimately benefiting diverse immunology-related careers.

Understanding compensation is crucial when planning a career. Transparency about earnings can guide decision-making, especially for those pursuing advanced degrees. Resources covering dnp salary transparency offer insights into expected income based on location, helping students align their goals with financial realities.

Best Scientists Citing Sylvie van der Werf

Trending Scientists